PEX2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.628600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.332400E-01
Normal-vs-Stage2
4.872000E-01
Normal-vs-Stage3
2.437600E-01
Normal-vs-Stage4
5.186000E-01
Stage1-vs-Stage2
7.065600E-01
Stage1-vs-Stage3
3.938000E-01
Stage1-vs-Stage4
2.939200E-01
Stage2-vs-Stage3
4.013800E-01
Stage2-vs-Stage4
4.531500E-02
Stage3-vs-Stage4
1.289450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.448200E-01
Normal-vs-AfricanAmerican
3.778200E-01
Normal-vs-Asian
4.682200E-01
Caucasian-vs-AfricanAmerican
6.269000E-01
Caucasian-vs-Asian
4.126800E-01
AfricanAmerican-vs-Asian
9.226400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.754200E-01
Normal-vs-Female
5.589600E-01
Male-vs-Female
9.318400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.109400E-01
Normal-vs-Age(41-60Yrs)
6.296400E-01
Normal-vs-Age(61-80Yrs)
5.483400E-01
Normal-vs-Age(81-100Yrs)
6.803800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.129400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.594800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.450000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.564200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.732200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.427400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.327000E-01
Normal-vs-Daily Drinker
5.692400E-01
Normal-vs-Weekly Drinker
3.502000E-01
Normal-vs-Occasional Drinker
7.942200E-01
Normal-vs-Social Drinker
4.885400E-01
Non Drinker-vs-Daily Drinker
7.281600E-01
Non Drinker-vs-Weekly Drinker
6.606400E-01
Non Drinker-vs-Occasional Drinker
2.230500E-02
Non Drinker-vs-Social Drinker
6.979200E-01
Daily Drinker-vs-Weekly Drinker
5.530200E-01
Daily Drinker-vs-Occasional Drinker
1.183980E-01
Daily Drinker-vs-Social Drinker
9.795400E-01
Weekly Drinker-vs-Occasional Drinker
4.591900E-02
Weekly Drinker-vs-Social Drinker
5.178600E-01
Occasional Drinker-vs-Social Drinker
1.196360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.185580E-02
Normal-vs-Grade 2
1.805890E-04
Normal-vs-Grade 3
4.444600E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.945000E-01
Grade 1-vs-Grade 3
2.856600E-01
Grade 1-vs-Grade 4
1.185580E-02
Grade 2-vs-Grade 3
4.855000E-01
Grade 2-vs-Grade 4
1.805890E-04
Grade 3-vs-Grade 4
4.444600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.764600E-01
Normal-vs-NonDiabetic
5.283200E-01
Diabetic-vs-NonDiabetic
7.932600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.018600E-01
Normal-vs-NoPancreatitis
5.643000E-01
Pancreatitis-vs-NoPancreatitis
6.519600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.942200E-01
Normal-vs-N1
5.291400E-01
N0-vs-N1
6.184600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.123600E-01
Normal-vs-TP53-NonMutant
6.757600E-01
TP53-Mutant-vs-TP53-NonMutant
8.618000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
